Search
for
Sort by
Research 301–330 of 1000+
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System
- Racial and Ethnic Disparities in Persistent Chemotherapy-Induced Alopecia Among Women With Breast Cancer
- Therapeutic Potential of Chitosan-Based and Related Nanocomposite Systems in Wound Management: A Review
- Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas
- Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China
- Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib
- Extracellular Vesicles in Regenerative and Cosmetic Medicine: Safety, Clinical Effectiveness, Therapeutic Applications, and Regulatory Challenges
- Erlotinib-induced trichomegaly of eyelashes in lung cancer treatment: Epidermal growth factor receptor inhibitor side effect
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
- Cemiplimab-Induced Alopecia Areata
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth? - eScholarship
- Polymeric nanoparticles‐based topical delivery systems for the treatment of dermatological diseases
- Dermatologic Signs in Patients with Eating Disorders
- Nanoparticles for Topical Application in the Treatment of Skin Dysfunctions—An Overview of Dermo-Cosmetic and Dermatological Products
- Traditional Uses and Pharmacologically Active Constituents of Dendrobium Plants for Dermatological Disorders: A Review
- Dermatological medication effects on male fertility
- Dermatological side effects of epidermal growth factor receptor inhibitors: ′Pride′ complex
- The assessment of dermatological needs in resource‐poor regions
- Analysis of dermatologic conditions in Turkey and Italy by using Google Trends analysis in the era of the COVID ‐19 pandemic
- Dermatological symptoms and sexual abuse: a review and case reports
- Dermatological Manifestations of Down's Syndrome
- Dermatological effects of <i>Curcuma</i> species: a systematic review
- Update dermatologic laser therapy
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19)
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Rational Design and Synthesis of 4-((1<i>R</i>,2<i>R</i>)-2-Hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a Novel, Nonsteroidal Androgen Receptor Antagonist Devoid of Phototoxicity for Dermatological Indications